InsidersTradesSigma
Follow the Siemens Healthineers AG stock price and the full insider trade history of the company, a publicly traded company based in Germany. Shares are quoted on the DE market, under the authority of BaFin. Operating in the Healthcare & Pharma sector, Siemens Healthineers AG has logged 19 public disclosures. Market capitalisation: €38.6bn. The latest transaction was filed on 30 March 2026 (Buy). Among the most active insiders: Staudinger-Leibrecht, Elisabeth. The full history is free.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Siemens Healthineers AG Buy (bullish), based on 20 analysts. Average price target: €45.65.
17Σ signal
Fundamental score
Ranked 5,739 of 29,063 companies
66.9
score / 100
Value65
Quality69
FCF yld5.4%
Earn yld4.9%
EV/EBITDA9.5x
ROE11%
Gross mgn38%
Net mgn8.7%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 March 2026
Declarations19 total
5,366.554 shares@ €36.960.0005% mcap100.0% of flowShareXETRAISIN DE000SHL1006BAFIN:40026744-e33058f6d995
500 shares@ €37.950.0001% mcap65.4% of flowShareING DirekthandelISIN DE000SHL1006BAFIN:40026744-aba7813f8f50
ShareISIN DE000SHL1006BAFIN:40026744-db238dc9193a
250 shares@ €40.2034.6% of flowShareING DirekthandelISIN DE000SHL1006BAFIN:40026744-7b54efb248ba
4,656.56 shares@ €42.96100.0% of flowShareXETRAISIN DE000SHL1006BAFIN:40026744-23867959ddb7
ShareISIN DE000SHL1006BAFIN:40026744-a958bd871f1b
ShareISIN DE000SHL1006BAFIN:40026744-7c8f77bbdbc1
ShareISIN DE000SHL1006BAFIN:40026744-d7cae707d1bd
ShareISIN DE000SHL1006BAFIN:40026744-731bca46f1a1
ShareISIN DE000SHL1006BAFIN:40026744-29539b5d2ea4
ShareISIN DE000SHL1006BAFIN:40026744-16eaee9ed15e
ShareISIN DE000SHL1006BAFIN:40026744-2fe6a9d67b08
ShareISIN DE000SHL1006BAFIN:40026744-239dfc3fdb71
ShareISIN DE000SHL1006BAFIN:40026744-2e6dc9870921
ShareISIN DE000SHL1006BAFIN:40026744-4bf367d45399
2,256 shares@ €46.53100.0% of flowShareING DirekthandelISIN DE000SHL1006BAFIN:40026744-fc65d1129657
ShareISIN DE000SHL1006BAFIN:40026744-a4a9fa59b9e1
ShareISIN DE000SHL1006BAFIN:40026744
ShareISIN DE000SHL1006BAFIN:40026744-a4a9fa59b9e1-2
19 of 19 declarations
关于 Siemens Healthineers AG
西门子医疗（Siemens Healthineers AG）是一家全球医疗技术集团，在德国Xetra/法兰克福（DAX/MDAX/SDAX）上市，股票代码为SHL.DE。该公司向医院、实验室和护理提供商供应医疗保健技术，使其成为一个资本密集型医疗技术特许经营企业，并受医疗保健投资周期的影响。其总部位于巴伐利亚州埃尔朗根，地处西门子历史悠久的工业生态系统内。西门子医疗强调其在医疗保健技术领域超过125年的传承，而其当前的法人结构是在2018年完成分拆和首次公开募股后建立的。（[siemens-healthineers.com](https://www.siemens-healthineers.com/press/features/pf-hq-opening?utm_source=openai)) 该业务围绕三大战略支柱展开。影像业务涵盖诊断和介入影像，包括MRI、CT、超声、X射线和血管造影平台。诊断业务包括实验室诊断、分子医学、即时检测和相关服务。该集团还通过瓦里安（Varian）和先进疗法（Advanced Therapies）扩大了其治疗业务，这两者现在是其治疗策略的核心。这种结构使西门子医疗能够覆盖从检测到治疗的整个护理连续体，同时越来越多地将人工智能和数字化工作流程嵌入到其产品组合中。（[siemens-healthineers.com](https://www.siemens-healthineers.com/press/releases/cmd2025?utm_source=openai)) 在竞争方面，西门子医疗是全球医疗影像领域的领先企业之一，并在多个高端类别中占据强势地位，尤其是在介入影像、CT和综合癌症护理方面。其竞争优势在于庞大的装机量、与医疗系统建立的长期客户关系、经常性服务收入以及持续的创新管线。该公司还强调在数字、数据和人工智能以及数字患者孪生和精准治疗方面的优势。从地理上看，它拥有广泛的全球足迹，遍及欧洲、北美和亚太地区，尤其在美国市场占有重要份额。（[siemens-healthineers.com](https://www.siemens-healthineers.com/de/about?utm_source=openai)) 近期发展表明其运营执行力强劲。截至2025年9月30日的2025财年，西门子医疗报告可比收入增长5.9%，调整后息税前利润（EBIT）近€3.9 billion，调整后息税前利润率16.5%，自由现金流约€2.7 billion。2025年11月，该集团还公布了其新的战略阶段“全球提升健康”（Elevating Health Globally），围绕影像、精准治疗和诊断重组了财务报告，同时更加强调人工智能和临床合作。2026年初，西门子医疗继续宣布在介入影像和肿瘤相关应用领域推出新产品和扩展产品组合，凸显了其活跃的创新管线。（[siemens-healthineers.com](https://www.siemens-healthineers.com/press/releases/2025q4?utm_source=openai))
